» Articles » PMID: 32803145

Is It Infection or Rather Vascular Inflammation? Game-changer Insights and Recommendations from Patterns of Multi-organ Involvement and Affected Subgroups in COVID-19

Abstract

Coronavirus disease 2019 (COVID-19) is a serious illness that has rapidly spread throughout the globe. The seriousness of complications puts significant pressures on hospital resources, especially the availability of ICU and ventilators. Current evidence suggests that COVID-19 pathogenesis majorly involves microvascular injury induced by hypercytokinemia, namely interleukin 6 (IL-6). We recount the suggested inflammatory pathway for COVID-19 and its effects on various organ systems, including respiratory, cardiac, hematologic, reproductive, and nervous organ systems, as well examine the role of hypercytokinemia in the at-risk geriatric and obesity subgroups with upregulated cytokines' profile. In view of these findings, we strongly encourage the conduction of prospective studies to determine the baseline levels of IL-6 in infected patients, which can predict a negative outcome in COVID-19 cases, with subsequent early administration of IL-6 inhibitors, to decrease the need for ICU admission and the pressure on healthcare systems. Video abstract: http://links.lww.com/CAEN/A24.

Citing Articles

An Overview of Neurological and Psychiatric Complications During Post-COVID Period: A Narrative Review.

Li D, Wang Q, Jia C, Lv Z, Yang J J Inflamm Res. 2022; 15:4199-4215.

PMID: 35923904 PMC: 9342586. DOI: 10.2147/JIR.S375494.


Gut Microbiota Disruption in COVID-19 or Post-COVID Illness Association with severity biomarkers: A Possible Role of Pre / Pro-biotics in manipulating microflora.

Alharbi K, Singh Y, Almalki W, Rawat S, Afzal O, Altamimi A Chem Biol Interact. 2022; 358:109898.

PMID: 35331679 PMC: 8934739. DOI: 10.1016/j.cbi.2022.109898.


The microvascular hypothesis underlying neurologic manifestations of long COVID-19 and possible therapeutic strategies.

Cardiovasc Endocrinol Metab. 2021; 10(4):193-203.

PMID: 34765889 PMC: 8575441. DOI: 10.1097/XCE.0000000000000253.


Salivary markers and coronavirus disease 2019: insights from cross-talk between the oral microbiome and pulmonary and systemic low-grade inflammation and implications for vascular complications.

AbdelMassih A, Hassan A, Abou-Zeid A, Hassan A, Hussein E, Gadalla M Cardiovasc Endocrinol Metab. 2021; 10(3):162-167.

PMID: 34386717 PMC: 8352626. DOI: 10.1097/XCE.0000000000000242.


Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients.

Omar Osman I, Melenotte C, Brouqui P, Million M, Lagier J, Parola P Front Immunol. 2021; 12:625732.

PMID: 34194422 PMC: 8236950. DOI: 10.3389/fimmu.2021.625732.


References
1.
Pammer J, Reinisch C, Birner P, Pogoda K, Sturzl M, Tschachler E . Interferon-alpha prevents apoptosis of endothelial cells after short-term exposure but induces replicative senescence after continuous stimulation. Lab Invest. 2006; 86(10):997-1007. DOI: 10.1038/labinvest.3700461. View

2.
Xu L, Liu J, Lu M, Yang D, Zheng X . Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020; 40(5):998-1004. PMC: 7228361. DOI: 10.1111/liv.14435. View

3.
Lu M, Zhu J . The role of cytokines in Guillain-Barré syndrome. J Neurol. 2010; 258(4):533-48. DOI: 10.1007/s00415-010-5836-5. View

4.
Winters S, Moore Jr J, Clark B . Leydig cell insufficiency in hypospermatogenesis: a paracrine effect of activin-inhibin signaling?. Andrology. 2018; 6(2):262-271. DOI: 10.1111/andr.12459. View

5.
McGonagle D, ODonnell J, Sharif K, Emery P, Bridgewood C . Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2020; 2(7):e437-e445. PMC: 7252093. DOI: 10.1016/S2665-9913(20)30121-1. View